다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Rheumatology, v.40 no.2, 2001년, pp.205 - 211
Edwards, J. C. W. (University College London Centre for Rheumatology, London, UK) , Cambridge, G. (University College London Centre for Rheumatology, London, UK)
Objectives. An open study of B‐lymphocyte depletion was undertaken in rheumatoid arthritis (RA) patients to test the hypothesis that B lymphocytes may be essential to disease perpetuation.Methods. Five patients with refractory RA were treated with a monoclonal anti‐CD20 antibody, cyclophosphamide and prednisolone and followed for 12–17 months. Patient 2 received further treatments at 8 and 12 months and patient 4 at 11 months.Results. At 26 weeks all patients satisfied the American College of Rheumatology ACR50 and patients 1–3 the ACR70 criteria of improvement, without further therapy. Patients 1, 3 and 5 achieved ACR70 at 1 yr and rheumatoid factor (RF) levels fell to normal. In patients 3 and 5, B lymphocytes returned without relapse. Patient 2 relapsed at 28 weeks and patient 4 at 38 weeks, coincident with the return of B lymphocytes in the presence of raised RF levels. Both achieved ACR70 on retreatment. Adverse events were limited to respiratory episodes (two patients) and marginal thrombocytopenia (one patient).Conclusions. These findings are consistent with the concept that RA is critically dependent on B lymphocytes and suggest that B‐lymphocyte depletion may be a safe and effective therapy.
10.1016/S0140-6736(81)91107-7 Janossy G, Duke O, Poulter LW, Panayi G, Bofill M, Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte‐macrophage immunoregulation. Lancet1981; ii:839-42.
10.1002/art.1780400104 Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis. Arthritis Rheum1997;40:5-18.
10.1016/S0889-857X(21)00462-2 Muller‐Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am1995;21:675-90.
10.1016/S0307-742X(21)00604-4 Mannik M, Nardella FA. IgG rheumatoid factors and self association of these antibodies. Clin Rheum Dis1985; 11:551-72.
Edwards JCW. Is rheumatoid factor relevant. In: Bird H, Snaith ML, eds. Rheumatoid arthritis, questions and uncertainties. Chapter 1. Oxford: Blackwell Scientific, 1999:3-23.
Gardner DL. Rheumatoid arthritis: cell and tissue pathology. In: Gardner DL, ed. Pathological basis of connective tissue diseases. London: Edward Arnold, 1992:444-526.
10.1002/eji.1830240808 Thompson KM, Randen I, Børretzen M, Førre O, Natvig JB. Variable region gene usage of human monoclonal rheumatoid factors derived from healthy donors following immunization. Eur J Immunol1994;24:165-7.
10.4049/jimmunol.163.6.3116 Kyburz D, Corr M, Brinson DC, Von‐Damm A, Tighe H, Carson DA. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol1999;163:3116-22.
10.1016/S0167-5699(00)01589-9 Sutton B, Corper A, Bonagura V, Taussig M. The structure and origin of rheumatoid factors. Immunol Today2000; 21:177-82.
10.1084/jem.173.2.487 Roosnek E, Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med1991;173:487-9.
10.1093/rheumatology/37.2.126 Edwards JCW, Cambridge G. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br J Rheumatol1998;37:126-30.
10.1046/j.1365-2567.1999.00772.x Edwards JCW, Cambridge G, Abrahams VM. Do self‐perpetuating B lymphocytes drive human autoimmune disease. Immunology1999;97:1868-96.
10.1146/annurev.iy.13.040195.001015 Fearon DT, Carter RH. The CD19/CR2/TAPA‐1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol1995;13:127-49.
Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol1970;6:689-706.
10.1002/art.1780250911 Brown PB, Nardella FA, Mannik M. Human complement activation by self‐associated IgG rheumatoid factors. Arthritis Rheum1982;25:1101-7.
Edwards JCW, Sutton BJ, Grimmett J, Abrahams VM. Rheumatoid factor stereochemistry analysed by real space modelling [abstract]. Arthritis Rheum1998;42(Suppl.):S84.
10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G Abrahams VM, Cambridge G, Edwards JCW. Induction of tumour necrosis factor alpha production by human monocytes: a key role for FcγRIIIa in rheumatoid arthritis. Arthritis Rheum2000;43:608-16.
10.1046/j.1365-2567.1998.00491.x Bhatia A, Blades S, Cambridge G, Edwards JCW. Differential distribution of FcgRIIIa in normal human tissues. Immunology1998;94:56-63.
10.1046/j.1365-2249.1997.4061306.x Edwards JCW, Leigh RD, Cambridge G. Expression of molecules involved in B lymphocyte survival and differentiation by synovial fibroblasts. Clin Exp Immunol1997;108:407-14.
10.1172/JCI117685 Dechanet J, Merville P, Durand I, Banchereau J, Miossec P. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest1995;95:456-63.
10.1200/JCO.1997.15.10.3266 Maloney DG, Grillo‐Lopez AJ, Bodkin DJ. IDEC‐C2B8: results of a phase I multiple‐dose trial in patients with relapsed non‐Hodgkin's lymphoma. J Clin Oncol1997; 15:3266-74.
10.1200/JCO.1998.16.8.2825 McLaughlin P, Grillo‐Lopez AJ, Link BK et al. Rituximab chimeric anti‐CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four‐dose treatment program. J Clin Oncol1998;16:2825-33.
10.1016/0140-6736(92)92294-P Isaacs JD, Watts RA, Hazleman BL et al. Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet1992;340:748-52.
10.1002/1529-0131(199911)42:11<2281::AID-ANR4>3.0.CO;2-E Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis. Arthritis Rheum1999;42:2281-5.
10.1002/1529-0131(199911)42:11<2286::AID-ANR5>3.0.CO;2-X Snowden JA, Biggs JC, Milliken ST, Fuller A, Brooks PM. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum1999; 42:2286-92.
10.1002/1529-0131(199911)42:11<2275::AID-ANR3>3.0.CO;2-6 Breban M, Dougados M, Picard F et al. Intensified‐dose cyclophosphamide and granulocyte‐stimulating factor administration for haematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthritis Rheum1999; 42:2275-80.
10.1002/art.1780380602 Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum1995; 38:727-35.
10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti‐tumor necrosis factor alpha monoclonal antibody combined with low‐dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum1998;41:1552-63.
10.7326/0003-4819-130-6-199903160-00004 Moreland LW, Schiff MH, Baumgartner MD et al. Etanercept therapy in therapy for rheumatoid arthritis. Ann Intern Med1999;130:478-86.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.